Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CES1 | P23141 | 2/20 | 0.36 |
| ▸ | ACLY | P53396 | 2/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL3813522 | 1.00 | ALDH1A1 (0.42) | ALDH1A1L3MBTL1TSHRTHRBTP53 | |
| Trifluoroacetic Acid SCHEMBL30705423 | 1.00 | ALDH1A1 (0.42) | ALDH1A1L3MBTL1TSHRTHRBTP53 | |
| Trifluoroacetic Acid SCHEMBL27922651 | 1.00 | ALDH1A1 (0.42) | ALDH1A1L3MBTL1TSHRTHRBTP53 | |
| Trifluoroacetic Acid SCHEMBL4531143 | 1.00 | ALDH1A1 (0.42) | ALDH1A1L3MBTL1TSHRTHRBTP53 | |
| Trifluoroacetic Acid SCHEMBL2015479 | 1.00 | ALDH1A1 (0.42) | ALDH1A1L3MBTL1TSHRTHRBTP53 | |
| Trifluoroacetic Acid SCHEMBL1025679 | 1.00 | ALDH1A1 (0.42) | ALDH1A1L3MBTL1TSHRTHRBTP53 | |
| Trifluoroacetic Acid SCHEMBL4772775 | 1.00 | — | — | |
| Trifluoroacetic Acid SCHEMBL375389 | 1.00 | — | — | |
| Trifluoroacetic Acid SCHEMBL2484766 | 0.95 | ALDH1A1 (0.44) | ALDH1A1L3MBTL1TSHRTHRBTP53 | |
| Trifluoroacetic Acid SCHEMBL4598430 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118510762-A | As AMPK activators thiadiazolone derivatives | 贝塔吉能公司 | 2024-08-16 | — | — | CN | claimed |
| US-20250152619-A1 | POLYIMIDAZOLIUM-BASED CATIONIC ANTIMICROBIAL POLYMERS FOR NOVEL MASTITIS PROPHYLACTIC SOLUTIONS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2025-05-15 | — | — | US | disclosed |
| CN-118804756-A | Polyimidazolium-based cationic antimicrobial polymers for novel mastitis prevention solutions | 麻省理工学院 | 2024-10-18 | — | — | CN | disclosed |
| US-12098147-B2 | Compound having novel structure, complex comprising same, anti-cancer pharmaceutical composition, and anti-cancer drug | ETNOVA THERAPEUTICS CORP. (KR) | 2024-09-24 | — | — | US | disclosed |
| CN-118510762-A | As AMPK activators thiadiazolone derivatives | 贝塔吉能公司 | 2024-08-16 | — | — | CN | disclosed |
| CN-112533907-B | Compounds having novel structures, complexes comprising same, and anti-cancer pharmaceutical compositions and anti-cancer agents | 艾特诺瓦治疗公司 | 2024-02-06 | — | — | CN | disclosed |
| WO-2023132793-A2 | POLYIMIDAZOLIUM-BASED CATIONIC ANTIMICROBIAL POLYMERS FOR NOVEL MASTITIS PROPHYLACTIC SOLUTIONS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-07-13 | — | — | WO | disclosed |
| US-20230131111-A1 | BIODEGRADABLE POLYIMIDAZOLIUMS AND OLIGOIMIDAZOLIUMS | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2023-04-27 | — | — | US | disclosed |
| EP-4157919-A1 | BIODEGRADABLE POLYIMIDAZOLIUMS AND OLIGOIMIDAZOLIUMS | Nanyang Technological University (SG) | 2023-04-05 | — | — | EP | disclosed |
| CN-115836103-A | Biodegradable polyimidazolium and oligoimidazolium salts | 南洋理工大学 | 2023-03-21 | — | — | CN | disclosed |
| CN-115667223-A | Imidazolium reagents for mass spectrometry | 豪夫迈·罗氏有限公司 | 2023-01-31 | — | — | CN | disclosed |
| US-20220024911-A1 | COMPOUND HAVING NOVEL STRUCTURE, COMPLEX COMPRISING SAME, ANTI-CANCER PHARMACEUTICAL COMPOSITION, AND ANTI-CANCER DRUG | ETNOVA THERAPEUTICS CORP. (KR) | 2022-01-27 | — | — | US | disclosed |
| US-8426607-B2 | Substituted amino-benzimidazoles, medicaments comprimising said compound, their use and their method of manufacture | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-04-23 | — | — | US | disclosed |
| US-20110288139-A1 | SUBSTITUTED AMINO-BENZIMIDAZOLES, MEDICAMENTS COMPRIMISING SAID COMPOUND, THEIR USE AND THEIR METHOD OF MANUFACTURE | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-11-24 | — | — | US | disclosed |
| EP-2245016-A1 | SUBSTITUTED AMINO-BENZIMIDAZOLES, MEDICAMENTS COMPRISING SAID COMPOUND, THEIR USE AND THEIR METHOD OF MANUFACTURE | Boehringer Ingelheim International GmbH (DE) | 2010-11-03 | — | — | EP | disclosed |
| WO-2009092566-A1 | SUBSTITUTED AMINO-BENZIMIDAZOLES, MEDICAMENTS COMPRISING SAID COMPOUND, THEIR USE AND THEIR METHOD OF MANUFACTURE | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-07-30 | — | — | WO | disclosed |
| US-6919382-B2 | Preparation and uses of conjugated solid supports for boronic acids | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2005-07-19 | — | — | US | disclosed |
| WO-2004087669-A1 | NOVEL QUINOLINE, TETRAHYDROQUINAZOLINE, AND PYRIMIDINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF | TAISHO PHARMACEUTICAL CO. LTD. (JP) | 2004-10-14 | — | — | WO | disclosed |
| US-20030044840-A1 | Preparation and uses of conjugated solid supports for boronic acids | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE (CA) | 2003-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110288139-A1 | SUBSTITUTED AMINO-BENZIMIDAZOLES, MEDICAMENTS COMPRIMISING SAID COMPOUND, THEIR USE AND THEIR METHOD OF MANUFACTURE | PSEN1, AADAT, PSEN2 | ALDH1A1 735/4885L3MBTL1 3265/4885TSHR 4184/4885 |
| US-20230131111-A1 | BIODEGRADABLE POLYIMIDAZOLIUMS AND OLIGOIMIDAZOLIUMS | PCNA, CD68, TLR3 | ALDH1A1 2489/4885L3MBTL1 1257/4885TSHR 3743/4885 |
| US-12098147-B2 | Compound having novel structure, complex comprising same, anti-cancer pharmaceutical composition, and anti-cancer drug | TP53, TOP1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | ALDH1A1 962/4885L3MBTL1 4678/4885TSHR 4867/4885 |
| US-20030044840-A1 | Preparation and uses of conjugated solid supports for boronic acids | SLC43A1, SBDS, SLC7A5 | ALDH1A1 1529/4885L3MBTL1 3686/4885TSHR 1683/4885 |
| US-20220024911-A1 | COMPOUND HAVING NOVEL STRUCTURE, COMPLEX COMPRISING SAME, ANTI-CANCER PHARMACEUTICAL COMPOSITION, AND ANTI-CANCER DRUG | TOP1, ABCB1, ABCF1 | ALDH1A1 694/4885L3MBTL1 4810/4885TSHR 4863/4885 |
| US-20250152619-A1 | POLYIMIDAZOLIUM-BASED CATIONIC ANTIMICROBIAL POLYMERS FOR NOVEL MASTITIS PROPHYLACTIC SOLUTIONS | PIM1, PIM3, PIM2 | ALDH1A1 4647/4885L3MBTL1 652/4885TSHR 3828/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.